Atlas Trials

Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma

Clinical trial NCT06416930 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06416930
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pleural Mesothelioma
Start date
2024-06-20
Primary completion
2027-06-20
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.